{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:25:26Z","timestamp":1767911126899,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejso.2020.08.016","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T11:45:13Z","timestamp":1598442313000},"page":"143-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A 20-year experience"],"prefix":"10.1016","volume":"47","author":[{"given":"Fabio","family":"Carboni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orietta","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Settimio","family":"Zazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5115-3099","authenticated-orcid":false,"given":"Isabella","family":"Sperduti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.08.016_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jss.2018.09.032","article-title":"Trends in outcome after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"234","author":"Gani","year":"2019","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.ejso.2020.08.016_bib2","first-page":"99","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality","volume":"7","author":"Newton","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib3","doi-asserted-by":"crossref","unstructured":"Beal EW, Ahmed A, Grotz T, et\u00a0al. Trends in the indications for short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy Am J Surg doi: 10.1016\/j.amjsurg.2019.09.017.","DOI":"10.1016\/j.amjsurg.2019.09.017"},{"key":"10.1016\/j.ejso.2020.08.016_bib4","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jso.24248","article-title":"What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1.125 procedures","volume":"113","author":"Passot","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejogrb.2018.05.024","article-title":"Diaphragm disease in advanced ovarian cancer: predictability of pre-operative imaging and safety of surgical intervention","volume":"226","author":"Pounds","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejso.2020.08.016_bib6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ejso.2018.12.021","article-title":"Long term survival and perioperative propensity score matched outcomes in diaphragmatic interventions in cytoreductive surgery\u00a0+ intra-peritoneal chemotherapy","volume":"45","author":"Singh","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib7","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s12094-019-02195-8","article-title":"Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy","volume":"22","author":"Cascales Campos","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1245\/s10434-014-4083-x","article-title":"Outcome of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement","volume":"22","author":"Franssen","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib9","article-title":"An 18-year experience in diagnostic laparoscopy of peritoneal carcinomatosis: results from 744 patients","author":"Carboni","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2020.08.016_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1055-3207(03)00048-6","article-title":"Peritonectomy procedures","volume":"12","author":"Sugarbaker","year":"2003","journal-title":"Surg Oncol Clin"},{"key":"10.1016\/j.ejso.2020.08.016_bib11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11605-015-2743-1","article-title":"A\u00a0randomized trial of goal directed vs. standard therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"19","author":"Colantonio","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2020.08.016_bib12","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ejso.2013.10.015","article-title":"Postoperative infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carinomatosis: proposal and results from a prospective protocol study of prevention, surveillance and treatment","volume":"40","author":"Valle","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib13","unstructured":"U.S. Department of Health and Humans Services, National cancer intitutes of health. Common terminology criteria for adverse events (CTCAE) version 4.0. Published: May 28, 2009 (v4.03: June 14, 2010), n.d."},{"key":"10.1016\/j.ejso.2020.08.016_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.suronc.2015.11.003","article-title":"Complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: risk factors for ICU admission and morbidity prognostic score","volume":"25","author":"Malfroy","year":"2016","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib15","doi-asserted-by":"crossref","first-page":"635314","DOI":"10.1155\/2012\/635314","article-title":"Pulmonary complications following cytoreductive surgery and perioperative chemotherapy in 147 consecutive patients","volume":"2012","author":"Preti","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ejso.2020.08.016_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1245\/s10434-019-07797-8","article-title":"Diaphragmatic peritoneal stripping versus full-thickness resection in CRS\/HIPEC: is there a difference?","volume":"27","author":"Sullivan","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib17","first-page":"3627","article-title":"Long term survival and propensity score matched outcomes of diaphragmatic resections compared to stripping in cytoreductive surgery with intra-peritoneal chemotherapy","volume":"26","author":"Singh","year":"2019","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2020.08.016_bib18","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1245\/s10434-014-3891-3","article-title":"Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"21","author":"Ahmed","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12094-018-1944-y","article-title":"Goal-directed therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study","volume":"21","author":"Esteve-P\u00e9rez","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1245\/s10434-018-07092-y","article-title":"Restrictive intraoperative fluid therapy is associated with decreased morbidity and length of stay following hyperthermic intraperitoneal chemoperfusion","volume":"26","author":"Hendrix","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.21037\/jgo.2018.12.11","article-title":"The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"10","author":"Shamavonian","year":"2019","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","article-title":"Best practise for perioperative management of patients with cytoreductive surgery and HIPEC","volume":"43","author":"Rasp\u00e8","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib23","first-page":"532","article-title":"Ninety-day post-operative morbidity and mortality using the National Cancer Institute\u2019s common terminology criteria for adverse events better describe post-operative outcome after cytoreduction surgery and hyperthermic intraperitoneal chemotherapy","volume":"34","author":"Alyami","year":"2018","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.ejso.2020.08.016_bib24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ygyno.2015.12.004","article-title":"Diaphragmatic peritonectomy vs. full-thickness resection with pleurectomy during visceral-peritoneal-debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: a surgical-histological analysis","volume":"140","author":"Soleymani majd","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib25","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1245\/s10434-018-07091-z","article-title":"Pleuropulmonary recurrence following cytoreductive surgery for hyperthermic intraperitoneal chemoperfusion for appendiceal pseudomyxoma peritonei","volume":"26","author":"Beane","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib26","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1245\/s10434-016-5209-0","article-title":"Intrathoracic chemoperfusion decreases recurrences in patients with full-thickness diaphragm involvement with mucinous appendiceal adenocarcinoma","volume":"23","author":"Grotz","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib27","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.21873\/anticanres.12936","article-title":"Long-term survival and propensity score matched outcomes of bilateral vs. unilateral diaphragm interventions in cytoreductive surgery plus intra-peritoneal chemotherapy","volume":"38","author":"Singh","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2020.08.016_bib28","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1245\/s10434-019-07414-8","article-title":"Incidence, risk factors and prevention strategies for venous tromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"26","author":"Khan","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib29","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/jso.24746","article-title":"Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"116","author":"Rottenstreich","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.016_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1076029619890415","article-title":"Prevention of venous thromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: development of a physiotherapy program","volume":"25","author":"Li","year":"2019","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320307083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320307083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:07:52Z","timestamp":1755274072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320307083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0748798320307083"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.08.016","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A 20-year experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}